Zdrowie i gospodarka · 21/05/1998

FDA Clears Way for Generic Carbinoxamine Maleate Tablets

The FDA has ruled that carbinoxamine maleate 4-mg tablets, sold under the brand name Clistin, were not withdrawn from the market due to safety or efficacy concerns, paving the way for generic versions to be approved.